May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 8:1 non-enriched, low potassium, 24 mEq K, packaged in 300 mL per bag, Rx only, Centr
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 8:1 non-enriched, HIGH POTASSIUM, 70 mEq K, packaged in 300 mL per bag, Rx only, Centra
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Microplegia Solution, HIGH POTASSIUM (100 mEq), packaged in 200 mL per bag, Rx only, Central Admixture Pharmacy Services
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1 Plasmalyte, HIGH POTASSIUM, HIGH K, packaged in 542 mL per bag, Rx only, Central Ad
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 4:1 Plasmalyte, low potassium, low K, packaged in 1047 mL per bag, Rx only, Central A
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, packaged in 1000 mL per bag, Rx only, Centra
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL per bag, Rx only, Cent
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1 in Ringer's, HIGH POTASSIUM, 48 mEq K, packaged in 522.8 mL per bag, Rx only, Centr
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 4:1 in Ringer's, low potassium, 12 mEq K, packaged in 504.8 mL per bag, Rx only, Cent
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODIUM BICARBONATE, 106 mEq K, packaged in 1000
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Modified St Thomas Solution, low potassium, HIGH SODIUM BICARBONATE, 62 mEq K, packaged in 1000 m
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, del Nido Formula, packaged in 1,052.8 mL per bag, Rx only, Central Admixture Pharmacy Services, I
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 4:1 Plasma-Lyte/Tromethamine, low potassium, packaged in 1000 mL per bag, Rx only, Ce
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1 Plasma-Lyte/Tromethamine, High Potassium, packaged in 500 mL per bag, Rx only, Cent
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 8:1 High Potassium/low dextrose, 100 mEq K, packaged in 500 mL per bag, Rx only, Centra
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1 High Potassium, 30 mEq K, packaged in 415 mL per bag, Rx only, Central Admixture Ph
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture P
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 4:1 low potassium/low tromethamine, 36 mEq K, packaged in 1000 mL per bag, Rx only, C
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Maintenance 4:1 low potassium, 20 mEq K, packaged in 810 mL per bag, Rx only, Central Admixture P
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 8:1 High Potassium, 108 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture P
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1, HIGH POTASSIUM/low tromethamine, 36 mEq K, packaged in 500 mL per bag, Rx only, Ce
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Induction 4:1, High Potassium, 60 mEq K, packaged in 830 mL per bag, Rx only, Central Admixture P
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Transplant Solution (Plasma-Lyte A), packaged in 165 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Leh
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Microplegia Solution, MSA/MSG 0.92 Molar with CP2D, packaged in 120 mL per bag, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Warm Induction 4:1 HIGH POTASSIUM/low tromethamine, 40 mEq K, packaged in 500 mL per bag, Rx only
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Reperfusate 4:1 low potassium/low tromethamine, 15 mEq K, packaged in 500 mL per bag, Rx only, Ce
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.5 mL per bag, Rx only, Central Admixture
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Reperfusate 4:1 low potassium, 7.5 mEq K, packaged in 238.75 mL per bag, Rx only, Central Admixtu
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Reperfusate No Potassium, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Servi
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
May 31, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, Reperfusate No Potassium, packaged in 238.75 mL per bag, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.